Jakob M. Riedl
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Cancer Research
- Molecular Biology
- Co-authors
- Armin GergerMartin PichlerMichael StotzJoanna SzkanderaFlorian PoschHerbert StögerMaria Anna SmolleDominik A. Barth
- Topics
- Cancer Genomics and Diagnostics (8 papers)Cancer Immunotherapy and Biomarkers (8 papers)Inflammatory Biomarkers in Disease Prognosis (8 papers)
- Cited by
- OncologyInternal MedicineImmunology
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Jakob M. Riedl
41 papers receiving 823 citations
Peers
Comparison fields: 5 of 81
- Oncology 561
- Pulmonary and Respiratory Medicine 262
- Immunology 225
- Cancer Research 157
- Molecular Biology 126
Countries citing papers authored by Jakob M. Riedl
This map shows the geographic impact of Jakob M. Riedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob M. Riedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob M. Riedl more than expected).
Fields of papers citing papers by Jakob M. Riedl
This network shows the impact of papers produced by Jakob M. Riedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob M. Riedl. The network helps show where Jakob M. Riedl may publish in the future.
Co-authorship network of co-authors of Jakob M. Riedl
This figure shows the co-authorship network connecting the top 25 collaborators of Jakob M. Riedl. A scholar is included among the top collaborators of Jakob M. Riedl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob M. Riedl. Jakob M. Riedl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 11 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 18 | |
| 8 | 4 | |
| 9 | 22 | |
| 10 | 19 | |
| 11 | 37 | |
| 12 | 28 | |
| 13 | 24 | |
| 14 | 2 | |
| 15 | 6 | |
| 16 | 7 | |
| 17 | 9 | |
| 18 | 6 | |
| 19 | 10 | |
| 20 | 81 |
About Jakob M. Riedl
Jakob M. Riedl is a scholar working on Internal Medicine, Oncology and Cancer Research, having authored 44 papers that have together received 833 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Inflammatory Biomarkers in Disease Prognosis (8 papers). The work is most often cited by research in Oncology (561 citations), Internal Medicine (42 citations) and Immunology (225 citations). Jakob M. Riedl has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Armin Gerger, Martin Pichler, Michael Stotz, Joanna Szkandera, Florian Posch, Herbert Stöger, Maria Anna Smolle, Dominik A. Barth, Alexander Siebenhüner and Thomas Winder. Their work appears in journals such as Journal of Clinical Oncology, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.